Yuan L, Wang D, Chen J, Lyu Y, Feng E, Zhang Y
Biology (Basel). 2023; 12(5).
PMID: 37237459
PMC: 10215202.
DOI: 10.3390/biology12050645.
Zaide G, Elia U, Cohen-Gihon I, Israeli M, Rotem S, Israeli O
Microorganisms. 2020; 8(12).
PMID: 33265965
PMC: 7760947.
DOI: 10.3390/microorganisms8121896.
Ehling-Schulz M, Lereclus D, Koehler T
Microbiol Spectr. 2019; 7(3).
PMID: 31111815
PMC: 6530592.
DOI: 10.1128/microbiolspec.GPP3-0032-2018.
Majumder S, Das S, Somani V, Makam S, Kingston J, Bhatnagar R
Front Immunol. 2019; 10:498.
PMID: 30941133
PMC: 6433990.
DOI: 10.3389/fimmu.2019.00498.
Ingavle G, Baillie L, Davies N, Beaton N, Zheng Y, Mikhalovsky S
Sci Rep. 2018; 8(1):7518.
PMID: 29760471
PMC: 5951949.
DOI: 10.1038/s41598-018-25678-0.
Trimethyl Chitosan Nanoparticles Encapsulated Protective Antigen Protects the Mice Against Anthrax.
Malik A, Gupta M, Mani R, Gogoi H, Bhatnagar R
Front Immunol. 2018; 9:562.
PMID: 29616046
PMC: 5870345.
DOI: 10.3389/fimmu.2018.00562.
Protection against inhalation anthrax by immunization with Ty21a stably producing protective antigen of .
Sim B, Li M, Osorio M, Wu Y, Wai T, Peterson J
NPJ Vaccines. 2017; 2:17.
PMID: 29263873
PMC: 5627300.
DOI: 10.1038/s41541-017-0018-4.
A Simple Luminescent Adenylate-Cyclase Functional Assay for Evaluation of Bacillus anthracis Edema Factor Activity.
Israeli M, Rotem S, Elia U, Bar-Haim E, Cohen O, Chitlaru T
Toxins (Basel). 2016; 8(8).
PMID: 27548219
PMC: 4999859.
DOI: 10.3390/toxins8080243.
Development of a Sterne-Based Complement Fixation Test to Monitor the Humoral Response Induced by Anthrax Vaccines.
Adone R, Sali M, Francia M, Iatarola M, Donatiello A, Fasanella A
Front Microbiol. 2016; 7:19.
PMID: 26858700
PMC: 4729949.
DOI: 10.3389/fmicb.2016.00019.
Surface plasmon resonance measurements of plasma antibody avidity during primary and secondary responses to anthrax protective antigen.
Lynch H, Stewart S, Kepler T, Sempowski G, Alam S
J Immunol Methods. 2013; 404:1-12.
PMID: 24316020
PMC: 4104170.
DOI: 10.1016/j.jim.2013.11.026.
Identification of the immunogenic spore and vegetative proteins of Bacillus anthracis vaccine strain A16R.
Liu X, Wang D, Ren J, Tong C, Feng E, Wang X
PLoS One. 2013; 8(3):e57959.
PMID: 23516421
PMC: 3596338.
DOI: 10.1371/journal.pone.0057959.
Recombinant GroEL enhances protective antigen-mediated protection against Bacillus anthracis spore challenge.
Sinha K, Bhatnagar R
Med Microbiol Immunol. 2012; 202(2):153-65.
PMID: 23263010
DOI: 10.1007/s00430-012-0280-z.
A novel mechanism for antibody-based anthrax toxin neutralization: inhibition of prepore-to-pore conversion.
Mechaly A, Levy H, Epstein E, Rosenfeld R, Marcus H, Ben-Arie E
J Biol Chem. 2012; 287(39):32665-73.
PMID: 22869370
PMC: 3463365.
DOI: 10.1074/jbc.M112.400473.
Humanized theta-defensins (retrocyclins) enhance macrophage performance and protect mice from experimental anthrax infections.
Welkos S, Cote C, Hahn U, Shastak O, Jedermann J, Bozue J
Antimicrob Agents Chemother. 2011; 55(9):4238-50.
PMID: 21768520
PMC: 3165295.
DOI: 10.1128/AAC.00267-11.
Analysis of antibody responses to protective antigen-based anthrax vaccines through use of competitive assays.
Brady R, Verma A, Meade B, Burns D
Clin Vaccine Immunol. 2010; 17(9):1390-7.
PMID: 20631338
PMC: 2944443.
DOI: 10.1128/CVI.00145-10.
Novel and unique diagnostic biomarkers for Bacillus anthracis infection.
Sela-Abramovich S, Chitlaru T, Gat O, Grosfeld H, Cohen O, Shafferman A
Appl Environ Microbiol. 2009; 75(19):6157-67.
PMID: 19648366
PMC: 2753070.
DOI: 10.1128/AEM.00766-09.
Isolation and chimerization of a highly neutralizing antibody conferring passive protection against lethal Bacillus anthracis infection.
Rosenfeld R, Marcus H, Ben-Arie E, Lachmi B, Mechaly A, Reuveny S
PLoS One. 2009; 4(7):e6351.
PMID: 19629185
PMC: 2710523.
DOI: 10.1371/journal.pone.0006351.
Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthrax.
Gauthier Y, Tournier J, Paucod J, Corre J, Mock M, Goossens P
Infect Immun. 2008; 77(3):1197-207.
PMID: 19114543
PMC: 2643630.
DOI: 10.1128/IAI.01217-08.
Recombinant Bacillus anthracis spore proteins enhance protection of mice primed with suboptimal amounts of protective antigen.
Cybulski Jr R, Sanz P, McDaniel D, Darnell S, Bull R, OBrien A
Vaccine. 2008; 26(38):4927-39.
PMID: 18657585
PMC: 2586003.
DOI: 10.1016/j.vaccine.2008.07.015.
Application of in vivo induced antigen technology (IVIAT) to Bacillus anthracis.
Rollins S, Peppercorn A, Young J, Drysdale M, Baresch A, Bikowski M
PLoS One. 2008; 3(3):e1824.
PMID: 18350160
PMC: 2265799.
DOI: 10.1371/journal.pone.0001824.